Fieldpoint Private Securities’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding PGEN
TS
MVP
IAM
Fieldpoint Private Securities's PGEN Position: Q4 2017 in Review
Fieldpoint Private Securities sold out of Precigen (PGEN) in Q4 2017, closing a stake of 700 shares — an estimated $13K sold.
Fieldpoint Private Securities first reported a position in PGEN in Q1 2017 and held it in 2 quarters. The position peaked at $14K in Q1 2017. 162 funds tracked by Wall St. Rank hold PGEN as of Q4 2017.
- Fieldpoint Private Securities reported no remaining Precigen position as of Q4 2017 after selling out during the quarter.
- Fieldpoint Private Securities sold 700 Precigen shares in Q4 2017, an estimated $13K.
- Fieldpoint Private Securities first reported a position in Precigen in Q1 2017 and held it in 2 quarters.
- Fieldpoint Private Securities's Precigen position peaked at $14K in Q1 2017.
- 162 funds tracked by Wall St. Rank held Precigen as of Q4 2017.
Based on Fieldpoint Private Securities's 13F filing for Q4 2017, filed 15 Feb 2018.